Detalhe da pesquisa
1.
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.
J Clin Oncol
; 42(11): 1288-1300, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38301187
2.
Nelfinavir induces liposarcoma apoptosis and cell cycle arrest by upregulating sterol regulatory element binding protein-1.
Anticancer Drugs
; 17(8): 891-903, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16940799